Kimberley M. Heinhuis

METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

L.L. Siu, Drew Rasco, S. P. Vinay et al. · Annals of Oncology · 2019 · 130 citations · Full text

Molecular Biology, Advanced Solid Tumours, Anti-cancer Agent +6

Detection and localization of early- and late-stage cancers using platelet RNA

Sjors G. J. G. In ‘t Veld, Mohammad Arkani, Edward P. Post et al. · Cancer Cell · 2022 · 108 citations · Full text

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

Martin Gutierrez, Víctor Moreno, Kimberley M. Heinhuis et al. · Clinical Cancer Research · 2020 · 105 citations · Full text

Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor–Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors

Kimberley M. Heinhuis, Matteo S. Carlino, Markus Joerger et al. · JAMA Oncology · 2019 · 90 citations · Full text

RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics

Kimberley M. Heinhuis, Sjors G. J. G. In ‘t Veld, Govert Dwarshuis et al. · Cancers · 2020 · 54 citations · Full text